BMS floats nutritionals business
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibb has successfully listed its nutritionals business Mead Johnson for $720 million on the New York Stock Exchange. The IPO is the first in about three months and is the largest for nearly 10 months after the global financial turmoil dried up the public markets.